Industry Verticals »

All Categories

Insights »

About TMR »

Neurovascular Embolization Devices (Neurology) Market

Neurovascular Embolization Devices (Neurology) Market (Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, and Others; Treatment: Ischemic Stroke Solutions and Hemorrhagic Stroke Solutions; Indication: Brain Aneurysms, Arteriovenous Malformation (AVM), and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

WEB Devices Emerge as Less-invasive Alternative for Neurovascular Embolization Treatment

Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.

WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.

neurovascular embolization devices neurology market infographic

Get a glimpse of the in-depth analysis through our Report Brochure

Healthcare Companies Scale Market Growth with Flow-diverting Devices

Recent advances in device technology are more focused on the control and precision of device placement during deployment procedures. To achieve this, healthcare companies in the neurovascular embolization devices (neurology) market are innovating in flow diversion technology. This is evident, as among the products in the neurovascular embolization devices (neurology) market, flow diversion stents are estimated to have the second-highest revenue of ~US$ 215 million by 2027.

Flow diversion technology has triggered the need for improved devices in the neurovascular embolization devices (neurology) landscape. As such, manufacturers are increasing the availability of flow-diverting devices for use in hospitals and ambulatory surgical centers. However, flow-diverting devices lead to challenging complications such as vertebrobasilar aneurysms in patients. Thus, healthcare companies are overcoming this limitation by seeking licensed approval from health commissions, so that their devices are credible. They are increasing research & development to validate clinically-approved data on the long-term benefits of using flow-diverting devices.

To know the scope of our report Get a Sample on Neurovascular Embolization Devices (Neurology) Market 

PED and Pipeline Flex: Reliable Treatment Options for Bifurcation Aneurysms

Although flow diversion stents result in fewer complications in patients, lack of clinical evidence about their long-term outcome remains a matter of debate. This is why, healthcare companies in the neurovascular embolization devices (neurology) market are supporting the treatment infrastructure with pipeline embolization devices (PEDs). Since these devices are outperforming other endoluminal devices, manufacturers are promoting their application for bifurcation aneurysms.

Posterior circulation aneurysm is another driver that is demanding the need for PEDs in the neurovascular embolization devices (neurology) market. As such, manufacturers are introducing variations in braided stents, local porosity, and filament position modeled with cone beam computed tomography to provide critical information to healthcare providers, prior to surgical treatments. PED technology is being rapidly transformed into pipeline flex technology. Although limited studies prove its long-term outcomes, pipeline flex is found to be a safe treatment option, and it serves as a short-term efficacy alternative.

neurovascular embolization devices neurology market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

The adoption of WEB devices for neurovascular embolization treatment is relatively slow in European countries. Thus, manufacturers in the neurovascular embolization devices (neurology) market should increase production capabilities for WEB devices in North America, since this region is projected to account for the largest market share in the neurovascular embolization devices (neurology) market over the forecast period.

Although embolization coils and flow diversion stents account for a significant amount of the revenue in the market, health complications associated with these products act as a hurdle for manufacturers. Taking a cue from the North America market, manufacturers in Europe and Asia Pacific should develop and promote WEB devices that will help create more incremental opportunities in these high-growth regions.

To gain credibility in the market, healthcare companies should seek approvals, such as the FDA Premarket Approval (PMA), to strategically market their product offerings in the highly consolidated global neurovascular embolization devices (neurology) market.

Neurovascular Embolization Devices (Neurology) Market: Overview

  • The global neurovascular embolization devices (neurology) market was valued at ~US$ 1.2 Bn in the years 2018, and the market is anticipated to reach ~US$ 1.6 Bn by 2027, expanding at a CAGR of ~3% from 2019 to 2027.
  • North America, Europe, and Asia Pacific were major markets for neurovascular embolization devices (neurology) in 2018. The neurovascular embolization devices (neurology) market in Asia Pacific is expected to expand at a higher CAGR of ~% during the forecast period, as compared to all other regions.
  • Stroke is a cerebrovascular accident caused due to blockage of blood supply to the brain cells. It is a sudden death of some brain cells, as oxygen supply is affected due to a ruptured artery or vein that supplies blood to these cells.
  • Increase in incidence of neurovascular diseases across the globe, rise in the prevalence of stroke, increasing elderly patient pool, and surge in the demand for procedures that are minimally-invasive are factors that are anticipated to drive the global neurovascular embolization devices (neurology) market during the forecast period of 2019 to 2027.

Neurovascular Embolization Devices (Neurology) Market: Segment Analysis

  • Based on product, the global neurovascular embolization devices (neurology) market has been segmented into liquid embolic systems, embolization coils, aneurysm clips, flow diversion stents, and others. The embolization coils segment accounted for a major share of the neurovascular embolization devices (neurology) market in 2018.
  • Increase in the demand for embolization coils, as they are preferred over other products for the treatment of cerebral aneurysms with strong clinical trial data is likely to boost the growth of the segment.
  • The development of embolization-enabling stents has extended the application base of embolic coiling for treatment of wide-neck bifurcation aneurysms. These factors are anticipated to propel the demand for neurovascular embolization devices (neurology) in the near future.
  • The flow diverter stents segment is expected to grow at a rapid pace during the forecast period. Strong growth of the segment can be attributed to the launch of Bravo Flow Diverter by Cerenovus in Europe in August 2018. The device is designed to divert blood flow from cerebral aneurysms, thereby reducing the risk of rupture. Moreover, flow-diversion stents exhibit an increased surface area, which directs a high volume of blood away from the aneurysm and eliminates the requirement of coiling.
  • In terms of treatment, the global neurovascular embolization devices (neurology) market has been segmented into ischemic stroke solutions and hemorrhagic stroke solutions. The hemorrhagic stroke solutions segment is anticipated to expand at a substantial CAGR between 2019 and 2027.
  • Increase in the prevalence of high blood pressure and brain aneurysms is a key factor that leads to hemorrhagic stroke. Furthermore, it is one of the most common emergencies encountered in clinical practice affecting the elderly population, which is anticipated to boost the growth of the segment in the near future.
  • On the basis of indication, the global neurovascular embolization devices (neurology) market has been categorized into brain aneurysm, arteriovenous malformations, and others. Surge in the number of cases of complex cerebral aneurysms across the world, and launch of novel neurovascular embolization devices (neurology) such as embolic stents and coils, are estimated to propel the segment during the forecast period.
  • Based on end user, the global neurovascular embolization devices (neurology) market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals accounted for a dominant share of the global neurovascular embolization devices (neurology) market in 2018, owing to a surge in the demand for minimally-invasive procedures for the treatment of stroke.
  • The availability of expert and skilled neurosurgeons and increase in the adoption of technologically-advanced devices in hospitals are other factors anticipated to boost the growth of the hospitals segment in the near future.

Neurovascular Embolization Devices (Neurology) Market: Key Insights

  • Coiling is a preferred mode of treatment for both, ruptured and unruptured brain aneurysms, which were initially treated by surgical clippings. Research studies have indicated that, the long-term success rate of coiling in brain aneurysms is over 85%.
  • The success rate of endovascular coiling for the treatment of cerebral aneurysms has led to a paradigm shift from clippings to coiling. All these factors are anticipated to drive the growth of the global neurovascular embolization devices (neurology) market in the coming years.
  • The launch of innovative embolization systems by industry players is anticipated to augment the global neurovascular embolization devices (neurology) market in the near future.
  • Developing economies such as India and China offer significant opportunities in the neurovascular embolization devices (neurology) market. Major factors include:
    • Rise in the prevalence and incidence rate of stroke in developing countries such as India and China, and growing geriatric patient pool, offer significant opportunities to market players to exploit these untapped markets. This is expected to drive the neurovascular embolization devices (neurology) market in the near future. For instance, approximately 15% of the China’s population was aged over 60 years in 2015, which is expected to increase to 36.5% by 2050.
  • All these factors provide several opportunities to players in the neurovascular embolization devices (neurology) market in these regions.

Neurovascular Embolization Devices (Neurology) Market: Prominent Players

  • Key players in the global neurovascular embolization devices (neurology) market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global neurovascular embolization devices (neurology) market report are
    • DePuy Synthes (Johnson & Johnson Services, Inc.)
    • Terumo Medical Corporation
    • Stryker Corporation
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Acandis GmbH
    • BALT EXTRUSION
    • Spartan Micro, Inc.
    • B. Braun Melsungen AG.

Neurovascular Embolization Devices (Neurology) Market – Segmentation 

Product
  • Embolization Coils
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Aneurysm Clips
  • Others

Treatment
  • Ischemic Stroke Solutions
  • Hemorrhagic Stroke Solutions

Indication
  • Brain Aneurysms
  • Arteriovenous Malformation (AVM)
  • Others

End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of neurovascular embolization devices (neurology) market?

Neurovascular embolization devices (neurology) market is anticipated to reach ~US$ 1.6 Bn by 2027

What is the anticipated CAGR of the neurovascular embolization devices (neurology) market in the forecast period?

Neurovascular embolization devices (neurology) market to expand at a CAGR of ~3% from 2019 to 2027

What are the key driving factors for the growth of the neurovascular embolization devices (neurology) market?

Neurovascular embolization devices (neurology) market is driven by increase in incidence of neurovascular diseases across the globe

Which is the rising prominent segment in the neurovascular embolization devices (neurology) market?

The embolization coils product segment dominated the global neurovascular embolization devices (neurology) market

Who are the key players in the neurovascular embolization devices (neurology) market?

Key players in the global neurovascular embolization devices (neurology) market include Stryker Corporation, Terumo Medical Corporation, DePuy Synthes (Johnson & Johnson Services, Inc.), Boston Scientific Corporation, Acandis GmbH

    1. Preface 

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Market Outlook

        5.1. Key Industry Developments 

        5.2. Regulatory Scenario

        5.3. Reimbursement Scenario

        5.4. Key Mergers & Acquisitions

        5.5. Technological Advancements

    6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product 

        6.1. Introduction & Definition 

        6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            6.2.1. Embolization Coils

            6.2.2. Liquid Embolic Systems

            6.2.3. Flow Diversion Stents

            6.2.4. Aneurysm Clips

            6.2.5. Others

        6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product

    7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

        7.1. Introduction & Definition 

        7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            7.2.1. Ischemic Stroke Solution

            7.2.2. Hemorrhagic Stroke Solution

        7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment

    8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication 

        8.1. Introduction 

        8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            8.2.1. Brain Aneurysms

            8.2.2. Arteriovenous Malformation (AVM)

            8.2.3. Others

        8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication

    9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

        9.1. Introduction 

        9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            9.2.1. Hospitals

            9.2.2. Ambulatory Surgery Centers

            9.2.3. Specialty Clinics

        9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User

    10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

        10.1. Introduction 

        10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa  

        10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region

    11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

        11.1. Introduction

        11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            11.2.1. Embolization Coils

            11.2.2. Liquid Embolic Systems

            11.2.3. Flow Diversion Stents

            11.2.4. Aneurysm Clips

            11.2.5. Others

        11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            11.3.1. Ischemic Stroke Solution

            11.3.2. Hemorrhagic Stroke Solution

        11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            11.4.1. Brain Aneurysms

            11.4.2. Arteriovenous Malformation (AVM)

            11.4.3. Others

        11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            11.5.1. Hospitals

            11.5.2. Ambulatory Surgery Centers

            11.5.3. Specialty Clinics

        11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Treatment 

            11.7.3. By Indication

            11.7.4. By End User

            11.7.5. By Country/Sub-region

    12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

        12.1. Introduction

        12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            12.2.1. Embolization Coils

            12.2.2. Liquid Embolic Systems

            12.2.3. Flow Diversion Stents

            12.2.4. Aneurysm Clips

            12.2.5. Others

        12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            12.3.1. Ischemic Stroke Solution

            12.3.2. Hemorrhagic Stroke Solution

        12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            12.4.1. Brain Aneurysms

            12.4.2. Arteriovenous Malformation (AVM)

            12.4.3. Others

        12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            12.5.1. Hospitals

            12.5.2. Ambulatory Surgery Centers

            12.5.3. Specialty Clinics

        12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy 

            12.6.6. Rest of Europe

        12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By Treatment 

            12.7.3. By Indication

            12.7.4. By End User

            12.7.5. By Country/Sub-region

    13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

        13.1. Introduction

        13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            13.2.1. Embolization Coils

            13.2.2. Liquid Embolic Systems

            13.2.3. Flow Diversion Stents

            13.2.4. Aneurysm Clips

            13.2.5. Others

        13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            13.3.1. Ischemic Stroke Solution

            13.3.2. Hemorrhagic Stroke Solution

        13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            13.4.1. Brain Aneurysms

            13.4.2. Arteriovenous Malformation (AVM)

            13.4.3. Others

        13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            13.5.1. Hospitals

            13.5.2. Ambulatory Surgery Centers

            13.5.3. Specialty Clinics

        13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

            13.6.1. Japan

            13.6.2. China

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By Treatment 

            13.7.3. By Indication

            13.7.4. By End User

            13.7.5. By Country/Sub-region

    14. Latin America  Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

        14.1. Introduction

        14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            14.2.1. Embolization Coils

            14.2.2. Liquid Embolic Systems

            14.2.3. Flow Diversion Stents

            14.2.4. Aneurysm Clips

            14.2.5. Others

        14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            14.3.1. Ischemic Stroke Solution

            14.3.2. Hemorrhagic Stroke Solution

        14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            14.4.1. Brain Aneurysms

            14.4.2. Arteriovenous Malformation (AVM)

            14.4.3. Others

        14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            14.5.1. Hospitals

            14.5.2. Ambulatory Surgery Centers

            14.5.3. Specialty Clinics

        14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By Treatment 

            14.7.3. By Indication

            14.7.4. By End User

            14.7.5. By Country/Sub-region

    15. Middle East & Africa  Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

        15.1. Introduction

        15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

            15.2.1. Embolization Coils

            15.2.2. Liquid Embolic Systems

            15.2.3. Flow Diversion Stents

            15.2.4. Aneurysm Clips

            15.2.5. Others

        15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

            15.3.1. Ischemic Stroke Solution

            15.3.2. Hemorrhagic Stroke Solution

        15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

            15.4.1. Brain Aneurysms

            15.4.2. Arteriovenous Malformation (AVM)

            15.4.3. Others

        15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

            15.5.1. Hospitals

            15.5.2. Ambulatory Surgery Centers

            15.5.3. Specialty Clinics

        15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

            15.7.1. By Product

            15.7.2. By Treatment 

            15.7.3. By Indication

            15.7.4. By End User

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

        16.2.  Company Profiles

            16.2.1. Medtronic plc

                16.2.1.1. Company Description

                16.2.1.2. Business Overview

                16.2.1.3. Financial Overview

                16.2.1.4. Strategic Overview

                16.2.1.5. SWOT Analysis

            16.2.2. Stryker Corporation

                16.2.2.1. Company Description

                16.2.2.2. Business Overview

                16.2.2.3. Financial Overview

                16.2.2.4. Strategic Overview

                16.2.2.5. SWOT Analysis

            16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.) 

                16.2.3.1. Company Description

                16.2.3.2. Business Overview

                16.2.3.3. Financial Overview

                16.2.3.4. Strategic Overview

                16.2.3.5. SWOT Analysis

            16.2.4. B.Braun Melsungen AG 

                16.2.4.1. Company Description

                16.2.4.2. Business Overview

                16.2.4.3. Financial Overview

                16.2.4.4. Strategic Overview

                16.2.4.5. SWOT Analysis

            16.2.5. Penumbra, Inc.

                16.2.5.1. Company Description

                16.2.5.2. Business Overview

                16.2.5.3. Financial Overview

                16.2.5.4. Strategic Overview

                16.2.5.5. SWOT Analysis

            16.2.6. Acandis GmbH

                16.2.6.1. Company Description

                16.2.6.2. Business Overview

                16.2.6.3. Financial Overview

                16.2.6.4. Strategic Overview

                16.2.6.5. SWOT Analysis

            16.2.7. BALT EXTRUSION

                16.2.7.1. Company Description

                16.2.7.2. Business Overview

                16.2.7.3. Financial Overview

                16.2.7.4. Strategic Overview

                16.2.7.5. SWOT Analysis

            16.2.8. Terumo Medical Corporation

                16.2.8.1. Company Description

                16.2.8.2. Business Overview

                16.2.8.3. Financial Overview

                16.2.8.4. Strategic Overview

                16.2.8.5. SWOT Analysis

            16.2.9. Boston Scientific Corporation

                16.2.9.1. Company Description

                16.2.9.2. Business Overview

                16.2.9.3. Financial Overview

                16.2.9.4. Strategic Overview

                16.2.9.5. SWOT Analysis

            16.2.10. Spartan Micro, Inc.

                16.2.10.1. Company Description

                16.2.10.2. Business Overview

                16.2.10.3. Financial Overview

                16.2.10.4. Strategic Overview

                16.2.10.5. SWOT Analysis

    List of Tables

    Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario 

    Table 02: Physician Billing and Payment for Reimbursement

    Table 03: Key Mergers and Acquisitions

    Table 04: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 05: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017–2027

    Table 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017–2027

    Table 07: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017–2027

    Table 08: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 09: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 10: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 11: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

    Table 12: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

    Table 13: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

    Table 14: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 15: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 16: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

    Table 17: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

    Table 18: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

    Table 19: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 20: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 21: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

    Table 22: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

    Table 23: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

    Table 24: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 25: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 26: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

    Table 27: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

    Table 28: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

    Table 29: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 30: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 31: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

    Table 32: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

    Table 33: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

    List of Figures

    Figure 01: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027

    Figure 02: Neurovascular Embolization Devices (Neurology) Market – Key Industry Developments

    Figure 03: Market Drivers 

    Figure 04: Market Restraints

    Figure 05: Key Opportunities

    Figure 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, 2017–2027

    Figure 07: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product (2018)

    Figure 08: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment (2018)

    Figure 09: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication (2018)

    Figure 10: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User (2018)

    Figure 11: Europe Regulatory Approval Process

    Figure 12: Technological Advancements

    Figure 13: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 14: Global Neurovascular Embolization Devices Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 15: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embolization Coils, 2017–2027

    Figure 16: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liquid Embolic Systems, 2017–2027

    Figure 17: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Diversion Stents, 2017–2027

    Figure 18: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aneurysm Clips, 2017–2027

    Figure 19: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 20: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 21: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 22: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke Solution, 2017–2027

    Figure 23: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke Solution, 2017–2027

    Figure 24: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 25: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 26: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Aneurysms, 2017–2027

    Figure 27: Global Ne Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arteriovenous Malformations (AVMs), 2017–2027

    Figure 28: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 29: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 30: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 31: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

    Figure 32: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

    Figure 33: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

    Figure 34: Global Neurovascular Embolization Devices (Neurology) Market: Regional Outlook

    Figure 35: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Region, 2018 and 2027

    Figure 36: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Region, 2019–2027

    Figure 37: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 38: North America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country, 2018 and 2027

    Figure 39: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country, 2019–2027

    Figure 40: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 41: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 42: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 43: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 44: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 45: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 46: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 47: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 48: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 49: Europe Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 50: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 51: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 52: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 53: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 54: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 55: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 56: Europe N Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 57: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 58: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 59: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 60: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 61: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 62: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 63: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 64: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 65: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 66: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 67: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 68: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 69: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 70: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 71: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 72: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 73: Latin Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 74: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 75: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 76: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 77: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 78: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 79: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 80: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 81: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 82: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 83: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 84: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

    Figure 85: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

    Figure 86: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

    Figure 87: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

    Figure 88: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

    Figure 89: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

    Figure 90: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

    Figure 91: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

    Figure 92: Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018) 

Copyright © Transparency Market Research, Inc. All Rights reserved

Neurovascular Embolization Devices (Neurology) Market

Schedule a Call